XC243

· PHARMENTERPRISES LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XC243, covering 2024-04-30 to 2024-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis [Phase 2]